A patented collagen ingredient, UC-II from InterHealth Nutraceuticals, may be twice as effective as glucosamine and chondroitin for joint health, according to results of randomized, double-blind study.
Global launches of products containing the joint health ingredient glucosamine are seeing a slow but steady increase, with North America and Asia Pacific currently reporting the most new launches, according to Mintel.
Extracts from rosehip may reduce pain associated with osteoarthritis by 37 per cent, according to a meta-analysis of randomized controlled trials (RCTs).
The development of a new joint health drink made with glucosamine
for the US market highlights how the popular joint health
ingredient is spreading from the supplement arena to the food and
beverage category.
Triarco Industries has launched a
water-soluble, high-concentration version of liquid
glucosamine the company says is aimed at foods and beverages that
appeal to the "older" glucosamine-buying
demographic.
Researchers have associated methylsulfonylmethane, or MSM, to
protecting articular cartilage and reducing inflammation in
osteoarthritis - findings that could bolster the profile of the
ingredient for joint health.
France's Burgundy is redrawing its product catalogue to list only
innovative and differentiated products - a sea-change for the
six-year old company with its roots in the eponymous wine region.
A Spanish chondroitin sulfate manufacturer has weighed in on the
debate over the negative results of a meta-analysis recently
published in the Annals of Internal Medicine.
AOAC International has put out a call in search of a study director
for its upcoming collaborative studies on standardized methods for
joint health-supporting compound, MSM.
Unigen has been awarded a new patent on the use of free-b-ring
flavonoids from Chinese Skullcap, adding value for customers using
its Univestin ingredient in joint health products.
A single laboratory validation of a method for quantifying
chondroitin sulfate in dietary supplement ingredients has been
completed in California, bringing it one step closer to becoming an
AOAC official testing method for the ingredient.
InterHealth's collagen ingredient UC-II performed favorably in an
study on arthritic dogs, delivering a 62 percent decrease in
overall joint pain in arthritic dogs. If the results are repeated
in humans, it could boost the ingredient...
Demand and prices for glucosamine have stabilised after a
tumultuous couple of years, as the sheen of newness rubs off the
joint health ingredient and much-anticipated GAIT trial, though
positive, proves disappointing in design.
A risk assessment for glucosamine and chondroitin sulfate, has been
authored by the CRN, providing industry and consumers with
important information on safe dosage levels.
Glucosamine and chondroitin sulfate supplements "significantly
decreased" knee pain for people suffering from moderate-to-severe
osteoarthritis - a message that may not be getting through to
consumers.
Rising consumer demand for non-prescription jointcare remedies,
backed up by new research out this year, will create a positive
climate for growth of newer entrants to the joint health sector,
believes UK company Gee Lawson.
The positive results of the GAIT and GUIDE glucosamin/chondroitin
studies are an encouraging sign for the industry, says Cargill,
which makes a non-shellfish derived, vegetarian glucosamine
hydrochloride.
Glucosamine has been shown to be one of the most effective
ingredients for promoting joint health and relieving pain, but a
new study suggests that commercial supplements may contain too
little to do any good.
Salt Lake City based Weider Nutrition said yesterday it had boosted
its Schiff-branded joint care supplements by adding hyaluronic acid
to the Move Free product line.
Salt Lake City based Weider Nutrition has launched a new
Schiff-branded joint care supplement that combines an antioxidant,
hyaluronic acid (HA) and glucosamine for faster-acting relief.
A review of almost 50 glucosamine, chondroitin and MSM supplements
shows that some are unlikely to help patients with joint disease as
they do not contain sufficient amounts of the declared ingredients.
A dietary supplement derived from sternum collagen can improve the
pain and stiffness in osteoarthritis patients, claims maker BioCell
Technology, which suggests the product could be an alternative to
glucosamine supplements.
Minneapolis-based Cargill Health and Food Technologies (H&FT)
has launched a new chondritin sulfate ingredient for use in dietary
supplements and health products. The company claims OptaFlex is the
first solvent-free chondroitin...